methylphenidate 8.6 MG Disintegrating Oral Tablet [Cotempla]

RxNorm concept 1926855, branded drug (sbd). Prescribable name: Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet.

RxCUI: 1926855
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1926855 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

methylphenidate 6901

Other names

Cotempla 8.6 MG Disintegrating Oral Tablet

Related concepts

methylphenidate 8.6 MG (SCDC, consists of)
methylphenidate 8.6 MG [Cotempla] (SBDC, consists of)
Disintegrating Oral Tablet (DF, has dose form)
Cotempla (BN, has ingredient)
methylphenidate 8.6 MG Disintegrating Oral Tablet (SCD, tradename of)

Linked data

NDCs

70165010030

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1926855 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1926855 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1926855. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.